An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapy. Carruthers RL, Rotstein DL, Healy BC, Chitnis T, Weiner HL, Buckle GJ Mult Scler. 2014 May 22. PMID: 24852928. Abstract CommentRecommendBookmarkWatch